$99.80
-0.30-0.3%
Last update: Oct 23, 4:27 PM
Lantheus Holdings Inc (LNTH) Stock Price, Quote, News & History
LNTHNASDAQ
CapVest-backed Curium agrees to acquire Lantheus for up to $8B, expanding its global footprint in nuclear medicine.
You can purchase shares of Lantheus Holdings (NASDAQ:LNTH) through any online brokerage.
Other companies in Lantheus Holdings’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).
Lantheus Holdings has a consensus price target of $110.00.
The stock price for Lantheus Holdings (NASDAQ: LNTH) is $99.8 last updated October 23, 2026 at 4:27 PM EDT.
There are no upcoming dividends for Lantheus Holdings.
Lantheus Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Lantheus Holdings.
Lantheus Holdings is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision...
